Advertisement

Topics

Catalyst Biomedica Limited Company Profile

16:30 EDT 22nd September 2017 | BioPortfolio

Catalyst BioMedica is a company that enables and supports the translation of fundamental biomedical research into innovative products and technologies that will meet global healthcare needs. Catalyst is a business development subsidiary established by the Wellcome Trust to work with scientists and their host institutions. The Wellcome Trust is the world's largest medical research charity, with an annual expenditure of more than £600 million (US$900 million).

At Catalyst we aim to provide a complementary resource to University technology transfer professionals, to protect intellectual property, to administer the funding of selected applied research and to promote the delivery of benefits for healthcare. At the same time we want to ensure that the benefits of new technologies will be shared equitably among those who generate them and those who fund and facilitate their transfer to the commercial sector.

Location

183 Euston Road
London
NW1 2BE
United Kingdom

Contact

Phone: +44 (0) 207 611 8802
Fax: +44 (0) 207 611 8857
Email: catalyst@wellcome.ac.uk


News Articles [284 Associated News Articles listed on BioPortfolio]

Oxford BioMedica could pocket $100m on Novartis CAR-T cell success

Oxford BioMedica saw its share price jump 21% after the US FDA approved Kymriah, the gene modified cell therapy made with the firm’s lentiviral vectors.

Oxford BioMedica inks $100 million supply agreement

Oxford BioMedica has signed an agreement for the commercial and clinical supply of lentiviral vectors…

Oxford BioMedica (OXB) - Kymriah approved - royalties to OXB assured

Edison Investment Research - Pharmaceutical & healthcare - Oxford BioMedica: Kymriah (tisagenlecleucel/CTL019), for which Oxford BioMedica (OXB) provides the key lentiviral vector component, has been ...

Oxford BioMedica secures commercial supply licence from UK MHRA

Oxford BioMedica has been granted a Manufacturer/Importer License (MIA) from the UK Medicines and Healthcare products Regulatory Agency (MHRA), to manufacture and distribute lentiviral vector material...

Oxford BioMedica signs $100m CAR-T deal with Novartis

Oxford BioMedica has signed a deal worth up to $100m with Novartis to supply modified viruses used to generate its CAR-T therapies. The deal represents a major financial boost for the UK biotech fir...

Oxford BioMedica could get $100m following CAR-T approval

UK biotech Oxford BioMedica could earn more than $100 million from Novartis for providing a key component in the recently approved CAR-T cancer cell therapy. The FDA this week approved Novartis’ c...

Oxford BioMedica wins big contract for Novartis cell therapy

LONDON (Reuters) - Novartis has signed a major contract with Oxford BioMedica that could earn the British company more than $100 million over three years for supplying the Swiss drugmaker with materia...

Oxford BioMedica (OXB) - CTL019 approval likely in pALL, ad-com positive

Edison Investment Research - Pharmaceutical & healthcare - Oxford BioMedica: With a probable approval for Novartis’s CTL019 (tisagenlecleucel) (OXB manufacture a key component) in both paediatri...

PubMed Articles [648 Associated PubMed Articles listed on BioPortfolio]

Switch in Catalyst State: Single Bifunctional Bi-State Catalyst for Two Different Reactions.

Disclosed here is a molecular switch which responds to acid-base stimuli and serves as a bi-state catalyst for two different reactions. The two states of the switch serve as a highly active and poorly...

Overcoming the instability of nanoparticle based catalyst films in alkaline electrolysers by self-assembling and self-healing films.

Engineering stable electrodes using highly active catalyst nanopowders for electrochemical water splitting remains a notorious challenge. We report an innovative and general approach for attaining hig...

Isotopic studies of the ammonia decomposition reaction using lithium imide catalyst.

Ammonia decomposition using (15)N labelled ammonia was performed over a lithium imide catalyst with mass spectrometry. The results show that all the nitrogen is released from the bulk of the lithium i...

Microstructural observation of fuel cell catalyst inks by Cryo-SEM and Cryo-TEM.

In order to improve the electricity generation performance of fuel cell electric vehicles, it is necessary to optimize the microstructure of the catalyst layer of a polymer electrolyte fuel cell. The ...

Deactivation of a Cobalt Catalyst for Water Reduction via Valence Tautomerism.

The activity of the water reduction catalyst [CoIII(L1)(pyr)2]PF6 (1), where (L1)-2 is a bis-amido pyridine ligand and pyr is pyrrolidine, is investigated. Catalyst 1 has an overpotential of 0.54 V an...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Basic Knowledge of CPR Among Close Relatives of Heart Patients-check Status Quo and Attemp to Establish a Potential Plan to Implement This Knowledge

Cardiac arrest is a public health problem and is the leading cause of death in many parts of the world. Cardiac arrest can occur inside the hospital and outside it. In the United States a...

Companies [191 Associated Companies listed on BioPortfolio]

Catalyst Biomedica Limited

Catalyst BioMedica is a company that enables and supports the translation of fundamental biomedical research into innovative products and technologies that will meet global healthcare needs. Catalyst ...

Oxford BioMedica

Oxford BioMedica advanced gene therapy techniques.

Boston Biomedica Incorporated

Boston Biomedica, Inc. is an infectious diseases management company providing products and services for the detection and treatment of infectious diseases (ID) such as AIDS, Lyme Disease, and Viral He...

Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (“Catalyst”), is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow.Catalyst is focus...

General Catalyst Partners

General Catalyst Partners is a growth equity and venture capital firm that invests in exceptional entrepreneurs who are building the technology-based companies that will lead inno...

More Information about "Catalyst Biomedica Limited" on BioPortfolio

We have published hundreds of Catalyst Biomedica Limited news stories on BioPortfolio along with dozens of Catalyst Biomedica Limited Clinical Trials and PubMed Articles about Catalyst Biomedica Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Catalyst Biomedica Limited Companies in our database. You can also find out about relevant Catalyst Biomedica Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record